The purpose of the Boston University Alzheimer's Disease Core Center (BU) ADCC) is to promote research concerning Alzheimer's Disease (AD) at Boston University and throughout the country by providing information and materials from well characterized and unique patient and caregiver populations: the ambulatory and late-stage suburban population at the Bedford VA Medical Center and the racially, ethnically, and culturally diverse poor urban population served by the Boston University Hospital Home Medical Service (HMS). All patients enrolled in the Clinical Core will be assessed every six months with a comprehensive neuropsychological test battery. A neurological examination will be performed annually and blood will be obtained to isolate DNA for molecular genetic studies and stored. A detailed family history will be obtained and caregivers will be assessed yearly. The database will allow for longitudinal comparisons and the ability to correlate the progression of AD with its impact on caregivers. The Neuropathology Core will establish accurate pathological diagnoses, rigorous documentation and quantitation of neuropathological changes, produce endothelial cell lines, and collect, store and disburse postmortem tissues. The Education and Information Transfer Core will provide a comprehensive program of AD research development, dissemination, and utilization for professional caregivers with respect to symptom management. The BU ADCC will fund pilot projects to promote new AD research and foster the development of new AD investigators. The BU ADCC will closely cooperate with, and complement, the Massachusetts Alzheimer's Disease Research Center and other national Alzheimer centers. These multiple activities will be coordinated by the Administrative Core. Research in AA at Boston University is substantial in all areas, from basic molecular biology through health services research. The ADCC will strengthen existing research and create new research alliances across BU sites. It will greatly facilitate basic research on the pathogenesis of AD, applied research on patient management strategies, and research concerning the impact of disease burden on caregivers and society. In addition, it will help foster the integration of basic and applied research to better understand the biological basis of clinical symptoms.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
3P30AG013846-03S2
Application #
2841976
Study Section
Special Emphasis Panel (ZAG1 (30))
Project Start
1996-07-01
Project End
2001-06-30
Budget Start
1998-08-01
Budget End
1999-06-30
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Boston University
Department
Neurology
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Gallagher, Damien; Kiss, Alex; Lanctot, Krista L et al. (2018) Toward Prevention of Mild Cognitive Impairment in Older Adults With Depression: An Observational Study of Potentially Modifiable Risk Factors. J Clin Psychiatry 80:
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Chung, Jaeyoon; Zhang, Xiaoling; Allen, Mariet et al. (2018) Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer's disease. Alzheimers Res Ther 10:22
Farrar, Danielle C; Mian, Asim Z; Budson, Andrew E et al. (2018) Retained executive abilities in mild cognitive impairment are associated with increased white matter network connectivity. Eur Radiol 28:340-347
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Bis, Joshua C; Jian, Xueqiu; Kunkle, Brian W et al. (2018) Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation. Mol Psychiatry :
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Weintraub, Sandra; Besser, Lilah; Dodge, Hiroko H et al. (2018) Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord 32:10-17

Showing the most recent 10 out of 791 publications